Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × amivantamab × Head & Neck × Clear all

Phase

Status

Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 7 Tumor-Agnostic 1 Other solid neoplasm 1 Head & Neck 1 CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1

Interventions

Cisplatin 87 pembrolizumab 75 Radiotherapy 42 Carboplatin 38 Radiotherapy, Intensity-Modulated 34 Magnetic Resonance Spectroscopy 34 toripalimab 32 Gemcitabine 27 Docetaxel 26 Cetuximab 26 Specimen Handling 25 Paclitaxel 23 Surgical Procedures, Operative 20 Fluorouracil 20 Drug Therapy 20 Blood Specimen Collection 20 Biopsy 19 Radiation 18 Nivolumab 18 camrelizumab 14 Chemoradiotherapy 14 Platinum 13 tislelizumab 11 X-Rays 11 Surveys and Questionnaires 11 Capecitabine 11 1,2-diaminocyclohexaneplatinum II citrate 11 spartalizumab 10 Standard of Care 10 130-nm albumin-bound paclitaxel 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07276399 2026-03-13

OrigAMI-5

Janssen Research & Development, LLC

Phase 3 Recruiting

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon ⚡